Your search returned 12 results.

Results
	1.	Pertuzumab: increasing the options. MedStar authors: Nunes, Raquel Swain, Sandra M PMID: 24855727 Citation: Oncology (Williston Park). 28(3):199, 204, 210, 2014 Mar. Institution: Washington Cancer Institute Medline publication type: Comment Journal Article Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Nunes R, Swain SM Add to cart (remove)
	2.	Reply to a. Avan et Al. MedStar authors: Swain, Sandra M PMID: 25870094 Year: 2015 Citation: Journal of Clinical Oncology. 33(15):1712, 2015 May 20. Institution: Washington Cancer Institute Medline publication type: Comment Letter Form of publication: Journal Article All authors: Baselga J, Clark E, Kiermaier A, Swain S DOI: http://dx.doi.org/10.1200/JCO.2015.60.8398 Add to cart (remove)
	3.	Pertuzumab for the treatment of breast cancer. [Review] MedStar authors: Lynce, Filipa Swain, Sandra M PMID: 24921704 Year: 2014 Citation: Cancer Investigation. 32(8):430-8, 2014 Oct. Institution: Washington Cancer Institute Medline publication type: Journal Article Research Support, Non-U.S. Gov't Review Form of publication: Journal Article All authors: Lynce F, Swain SM DOI: http://dx.doi.org/10.3109/07357907.2014.922570 Add to cart (remove)
	4.	Pertuzumab for the treatment of breast cancer: a safety review. [Review] MedStar authors: Swain, Sandra M PMID: 26982349 Year: 2016 Citation: Expert Opinion on Drug Safety. 15(6):853-63, 2016 Jun Institution: Washington Cancer Institute Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Gao J, Swain SM DOI: https://dx.doi.org/10.1517/14740338.2016.1167185 Add to cart (remove)
	5.	Bevacizumab-induced atypical hemolytic uremic syndrome and treatment with eculizumab. MedStar authors: Alhaj-Moustafa, Muhamad Fitzpatrick, Kelly Pilla, Ravi Vakiti, Anusha PMID: 29768958 Year: 2019 Citation: Journal of Oncology Pharmacy Practice. 25(4):1011-1015, 2019 Jun. Institution: MedStar Washington Hospital Center Washington Cancer Institute Department: Medicine/General Internal Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Alhaj-Moustafa M, Fitzpatrick KW, Pilla R, Singh D, Vakiti A DOI: https://dx.doi.org/10.1177/1078155218774895 Add to cart (remove)
	6.	Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor-induced colitis: a multi-center study. MedStar authors: Alsaadi, Dana Charabaty, Aline Jennings, Joseph PMID: 30518410 Year: 2018 Citation: Journal for Immunotherapy of Cancer. 6(1):142, 2018 Dec 05. Institution: MedStar Washington Hospital Center Department: Gastroenterology/Hepatology Medline publication type: Journal Article Form of publication: Journal Article All authors: Abu-Sbeih H, Ali FS, Alsaadi D, Charabaty A, Gong Z, Jennings J, Luo W, Richards DM, Wang Y DOI: https://dx.doi.org/10.1186/s40425-018-0461-4 Add to cart (remove)
	7.	Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer. MedStar authors: Swain, Sandra M PMID: 23868905 Year: 2013 Citation: Annals of Oncology. 24(10):2630-5, 2013 Oct. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Baselga J, Clark E, Cortes J, Im SA, Im YH, Knott A, Pivot X, Ross G, Swain SM DOI: http://dx.doi.org/10.1093/annonc/mdt274 Add to cart (remove)
	8.	Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer. MedStar authors: Swain, Sandra M PMID: 25332247 Year: 2014 Citation: Journal of Clinical Oncology. 32(33):3753-61, 2014 Nov 20. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Baselga J, Clark E, Cortes J, Im SA, Kiermaier A, Ross G, Swain SM DOI: http://dx.doi.org/10.1200/JCO.2013.54.5384 Add to cart (remove)
	9.	Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31. MedStar authors: Swain, Sandra M PMID: 24262440 Year: 2013 Citation: Journal of the National Cancer Institute. 105(23):1782-8, 2013 Dec 4. Institution: Washington Cancer Institute Medline publication type: Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Bandos H, Blackmon NL, Bohn OL, Burandt E, Costantino JP, Fehrenbacher L, Fumagalli D, Gavin PG, Geyer CE Jr, Goldstein LC, Horne ZD, Jeong JH, Kim C, Kim SI, Kim SR, Lee A, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Reilly ML, Remillard MY, Romond EH, Sneige N, Swain SM, Tanaka N, Taniyama Y, Wickerham DL, Wolmark N DOI: http://dx.doi.org/10.1093/jnci/djt321 Add to cart (remove)
	10.	A patient with melanoma that became sensitized to immunotherapy after treatment with a CDK4/6 inhibitor. MedStar authors: Alzeer, Ali Hazem Zaemes, Jacob PMID: 32640856 Year: 2020 Citation: Immunotherapy. 12(12):861-867, 2020 08. Institution: MedStar Washington Hospital Center Department: Internal Medicine Residency Pathology Residency Medline publication type: Journal Article Form of publication: Journal Article All authors: Alzeer A, Atkins M, Villa K, Zaemes J DOI: https://dx.doi.org/10.2217/imt-2020-0139 Add to cart (remove)
	11.	Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab. MedStar authors: Priebat, Dennis A PMID: 31900276 Year: 2020 Citation: Clinical Cancer Research. 26(6):1258-1266, 2020 03 15. Institution: Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Attia S, Bolejack V, Burgess M, Davis LE, Hu J, Keung EZ, Lazar AJ, Movva S, Okuno S, Parra Cuentas E, Priebat DA, Reed DR, Reinke DK, Reuben A, Riedel RF, Rodrigues-Canales J, Roland CL, Salazar R, Schuetze SM, Tawbi HA, Van Tine BA, Wang WL, Wargo JA DOI: https://dx.doi.org/10.1158/1078-0432.CCR-19-1824 Add to cart (remove)
	12.	Identification and analysis of in vivo VEGF downstream markers link VEGF pathway activity with efficacy of anti-VEGF therapies. MedStar authors: Swain, Sandra M PMID: 23685835 Year: 2013 Citation: Clinical Cancer Research. 19(13):3681-92, 2013 Jul 1. Institution: Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Bais C, Brauer MJ, Chen D, Cheng JH, Chung AS, Clermont AC, Ferrara N, Haley B, Hegde P, James CD, Jubb A, Jurinka SS, Kaminker JS, Koeppen H, Kolumam G, Modrusan Z, Ozawa T, Phillips H, Scherer SJ, Schmidt M, Singh M, Stephan JP, Swain SM, Tam RN, Wu X, Yang SX, Yao J, Yeh RF, Yue P, Zhuang G DOI: http://dx.doi.org/10.1158/1078-0432.CCR-12-3635 Add to cart (remove)

Powered by Koha